Search
Previous exams
2024 exam
The most recent European Hematology Exam took place on June 13, 2024. In total, 244 candidates took the exam at 15 locations.
Master Class
Enhance your skills and expand your network with advanced online hematology training based on specially crafted clinical cases.
Read moreMembership
Boost your career, fast-track your development, and make new connections by joining a pioneering European hematology organization with global reach.
Read moreI4MDS consortium: advancing MDS treatment and understanding
The role of the immune system in the pathophysiology of Myelodysplastic Neoplasms (MDS) is firmly established. However, routine immune monitoring for these patients is still not a common practice.
Read moreChairs and members
Chair (2024–2027 term)Igor Aurer (education and scientific meetings co-lead) – University Hospital Centre Zagreb, University of Zagreb and KroHem, Croatia
Co-chair (2024–2027 term)Martin Dreyling (guidelines lead) – University Hospital Grosshadern, Ludwig Maximilian University and GLA, Germany
SWG Executive Board members (2024–2027 term)
Kim Linton (scientific secretary) –…
European Hematology Curriculum
Harmonization of hematology knowledge is part of EHA’s mission. The first step in harmonizing hematology training is to stipulate the required fields of knowledge, each with its recommended level of competence.
Read moreEHA Education & Mentoring Award
“Educating and mentoring are a brain to pick, an ear to listen, and a push in the right direction. ”
Through this award, EHA recognized excellent teachers and mentors at any stage of their career.
David Grimwade Award
In 2017, EHA established a new award in honor of the late David Grimwade, for his great involvement and contribution to the European Hematology Association and its scientific activities as Board Member, TRTH Co-Director and Chair of the Scientific Program…
Read moreFrom bedside to Brussels: hematology at the forefront of EU health policy
Access is at the heart of EHA's European Affairs work. More specifically, equitable and affordable access to innovative therapies that are of clear added benefit from a clinical, patient, and public health perspective.
Read more